We are live on
!
Find out more
Takeda Pharmaceutical
347 hedge funds and large institutions have $2.57B invested in Takeda Pharmaceutical in 2019 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 93 increasing their positions, 118 reducing their positions, and 86 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
30% less capital invested
Capital invested by funds: $3.64B → $2.57B (-$1.08B)
41% less first-time investments, than exits
New positions opened: 51 | Existing positions closed: 86
56% less funds holding in top 10
Funds holding in top 10: 16 → 7 (-9)
Holders
347
Holding in Top 10
7
Calls
$114M
Puts
$97.2M
Top Buyers
| 1 | +$57.7M | |
| 2 | +$24.4M | |
| 3 | +$16.1M | |
| 4 |
Renaissance Technologies
New York
|
+$14.1M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$13.2M |
Top Sellers
| 1 | -$121M | |
| 2 | -$88.3M | |
| 3 | -$86M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$44M |
| 5 |
Goldman Sachs
New York
|
-$40.8M |